文献速递肝病

维生素D补充对肝硬化患者维生素D水平及骨密度的影响:一项随机临床试验

Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

本研究纳入164例18-60岁任何病因的肝硬化患者,随机分为维生素D干预组和安慰剂组各82例,干预1年。结果显示干预组25(OH)D水平显著升高,但腰椎和左髋颈骨密度两组间无显著差异,其他指标亦无显著变化。

要点

  • 维生素D补充1年可显著提高肝硬化患者25(OH)D水平。
  • 补充维生素D未改善腰椎和左髋颈骨密度。
  • 钙、PTH、TSH、FT4、IGF-1、骨特异性碱性磷酸酶及生活质量无显著变化。

核心结论

  • 肝硬化患者补充维生素D1年可改善维生素D水平,但未改善腰椎和左髋颈骨密度。

研究设计与样本

  • 随机临床试验,筛查390例肝硬化患者,随机164例(干预组82例,安慰剂组82例),年龄18-60岁,任何病因。
  • 干预1年,在意向性治疗分析下比较25(OH)D和骨密度等指标。

主要发现

  • 干预1年后干预组25(OH)D水平显著高于安慰剂组(33.7 [24.3-45.7] ng/mL vs 23.1 [17-28.2] ng/mL;P < 0.001)。
  • 腰椎和左髋颈骨密度平均差异在两组间无显著变化。
  • 两组钙、TSH、PTH、FT4、IGF-1、骨特异性碱性磷酸酶及生活质量均无显著变化。

临床怎么用

  • 对于肝硬化患者,补充维生素D可纠正维生素D缺乏,但不应期望通过1年补充改善骨密度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In patients with cirrhosis, highly prevalent vitamin D deficiency and low bone mineral density (BMD) increase the burden of disease, and role of vitamin D supplementation is not clear. So, our aim was to determine the effect of vitamin D supplementation on vitamin D level and BMD in patients with cirrhosis. METHODS: Patients with cirrhosis (18-60 years) of any etiology were enrolled. We measured serum 25(OH)D, parathyroid hormone, thyroid-stimulating hormone, free T4, bone-specific alkaline phosphatase, insulin-like growth factor (IGF)-1, and health-related quality of life at entry and at 1 year; however, serum calcium was measured at 3-month interval. BMD was measured by dual-energy x-ray absorptiometry at lumbar spine and left hip neck at entry and after 1 year. Statistical analysis was performed according to intention-to-treat analysis. RESULTS: Of 390 screened patients with cirrhosis, 164 participants (82 in each group) were randomized. There was significant increase in 25(OH)D levels in intervention group after 1 year (33.7 [24.3-45.7] ng/mL vs 23.1 [17-28.2] ng/mL; P < 0.001) when compared with placebo. The mean difference in BMD at lumbar spine and left hip neck was not significantly changed after 1 year of intervention with vitamin D between both groups. There was no significant change in both the groups in levels of calcium, thyroid-stimulating hormone, parathyroid hormone, free T4, IGF-1, and bone-specific alkaline phosphatase and quality of life. DISCUSSION: Supplementation with vitamin D for 1 year improves vitamin D levels but did not result in improvement in BMD at lumbar spine and left hip neck in patients with cirrhosis.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Grover I, Gunjan D, Singh N, et al. Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial. Am J Gastroenterol. 2021. PMID: 33927126. doi:10.14309/ajg.0000000000001272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。